US Stock MarketDetailed Quotes
SLRX Salarius Pharmaceuticals
- 1.4800
- -0.1300-8.07%
Close Nov 1 16:00 ET
- 1.4800
- 0.00000.00%
Post 20:02 ET
2.13MMarket Cap-169P/E (TTM)
1.6100High1.4400Low53.16KVolume1.6100Open1.6100Pre Close80.60KTurnover3.78%Turnover RatioLossP/E (Static)1.44MShares7.440052wk High0.90P/B2.08MFloat Cap1.260052wk Low--Dividend TTM1.40MShs Float124099.9504Historical High--Div YieldTTM10.56%Amplitude1.2600Historical Low1.5160Avg Price1Lot Size
About Salarius Pharmaceuticals Company
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Company Profile
SymbolSLRX
Company NameSalarius Pharmaceuticals
Listing DateJan 29, 2015
Issue Price16.00
Founded2014
CEOMr. David J. Arthur
MarketNASDAQ
Employees2
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite X
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-832-834-6992
Websitehttp://salariuspharma.com
Company Executives
- Name
- Position
- Salary
- David J. Arthur
- Chief Executive Officer
- 544.60K
- Mark J. Rosenblum
- Executive Vice President, Finance and Chief Financial Officer
- 494.55K
- Dr. William K. McVicar, PhD
- Chairman of the Board
- 82.26K
- Jonathan I. Lieber, M.B.A.
- Independent Director
- 53.76K
- Dr. Paul Lammers, M. Sc.,M.D.
- Lead Independent Director
- 76.76K
- Tess Burleson
- Independent Director
- 64.76K
- Dr. Bruce McCreedy, PhD
- Independent Director
- 45.26K
- Arnold C. Hanish
- Independent Director
- 67.26K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data